Vanguard Group Inc. lifted its stake in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) by 2.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,293,272 shares of the company's stock after acquiring an additional 86,997 shares during the quarter. Vanguard Group Inc. owned 8.66% of Xometry worth $183,151,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the stock. Barclays PLC lifted its holdings in shares of Xometry by 360.9% during the third quarter. Barclays PLC now owns 68,951 shares of the company's stock valued at $1,266,000 after purchasing an additional 53,991 shares during the last quarter. Weiss Asset Management LP purchased a new stake in Xometry during the third quarter valued at about $1,586,000. Charles Schwab Investment Management Inc. boosted its holdings in shares of Xometry by 4.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 354,849 shares of the company's stock worth $6,519,000 after buying an additional 16,396 shares during the period. Centiva Capital LP purchased a new position in shares of Xometry in the third quarter worth approximately $341,000. Finally, State Street Corp increased its position in shares of Xometry by 0.3% in the third quarter. State Street Corp now owns 887,139 shares of the company's stock worth $16,297,000 after acquiring an additional 3,027 shares in the last quarter. 97.31% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on the stock. Wedbush reaffirmed an "outperform" rating and issued a $48.00 price objective on shares of Xometry in a research note on Friday, December 20th. JMP Securities reaffirmed a "market outperform" rating and issued a $42.00 target price on shares of Xometry in a research report on Monday, February 10th. Citigroup lowered their price target on Xometry from $46.00 to $39.00 and set a "buy" rating on the stock in a report on Thursday, February 27th. Cantor Fitzgerald increased their price objective on Xometry from $12.00 to $20.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 26th. Finally, Royal Bank of Canada lifted their target price on Xometry from $27.00 to $40.00 and gave the company a "sector perform" rating in a research note on Friday, January 3rd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Xometry has an average rating of "Moderate Buy" and an average target price of $36.11.
Get Our Latest Stock Analysis on Xometry
Insider Activity at Xometry
In other Xometry news, Director Emily Rollins sold 2,000 shares of the business's stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $20.66, for a total value of $41,320.00. Following the completion of the sale, the director now directly owns 16,146 shares of the company's stock, valued at $333,576.36. The trade was a 11.02 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Peter Goguen sold 3,000 shares of the stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $34.50, for a total transaction of $103,500.00. Following the transaction, the chief operating officer now owns 164,993 shares in the company, valued at approximately $5,692,258.50. This trade represents a 1.79 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 81,256 shares of company stock valued at $2,116,389. 16.79% of the stock is owned by corporate insiders.
Xometry Stock Up 2.5 %
XMTR stock traded up $0.53 during mid-day trading on Friday, hitting $21.48. The stock had a trading volume of 400,811 shares, compared to its average volume of 611,770. Xometry, Inc. has a 1-year low of $11.08 and a 1-year high of $45.33. The company has a fifty day moving average of $27.67 and a 200 day moving average of $29.26. The company has a current ratio of 4.59, a quick ratio of 4.55 and a debt-to-equity ratio of 0.90. The stock has a market capitalization of $1.08 billion, a price-to-earnings ratio of -20.46 and a beta of 0.72.
Xometry Profile
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Recommended Stories

Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.